GSA Capital Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,819
Closed -$591K 1855
2025
Q4
$591K Buy
+5,819
New +$467K 0.05% 703
2025
Q3
Sell
-4,762
Closed -$253K 1781
2025
Q2
$253K Buy
+4,762
New +$242K 0.02% 1370
2025
Q1
Sell
-4,034
Closed -$227K 1775
2024
Q4
$227K Buy
+4,034
New +$251K 0.02% 1352
2021
Q3
Sell
-2,791
Closed -$347K 1539
2021
Q2
$347K Buy
+2,791
New +$333K 0.04% 850
2019
Q2
Sell
-16,815
Closed -$1.46M 1526
2019
Q1
$1.46M Buy
16,815
+12,064
+254% +$1.03M 0.15% 134
2018
Q4
$300K Buy
+4,751
New +$326K 0.03% 840
2018
Q3
Sell
-10,683
Closed -$639K 1710
2018
Q2
$639K Buy
10,683
+2,477
+30% +$133K 0.03% 1024
2018
Q1
$331K Buy
+8,206
New +$400K 0.02% 1274
2017
Q3
Sell
-6,133
Closed -$217K 1684
2017
Q2
$217K Buy
+6,133
New +$189K 0.01% 1471
2016
Q4
Sell
-19,360
Closed -$360K 1814
2016
Q3
$360K Buy
+19,360
New +$341K 0.02% 1246
2015
Q4
Sell
-57,766
Closed -$1.04M 1856
2015
Q3
$1.04M Buy
57,766
+36,992
+178% +$850K 0.05% 598
2015
Q2
$618K Sell
20,774
-12,183
-37% -$306K 0.02% 1217
2015
Q1
$726K Buy
32,957
+15,457
+88% +$392K 0.03% 1136
2014
Q4
$480K Sell
17,500
-25,835
-60% -$629K 0.03% 948
2014
Q3
$840K Buy
+43,335
New +$795K 0.04% 601

Other funds holding EXAS

GSA Capital Partners's EXAS Position: Q1 2026 in Review

GSA Capital Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,819 shares — an estimated $591K sold.

GSA Capital Partners first reported a position in EXAS in Q3 2014 and held it in 15 quarters. The position peaked at $1.46M in Q1 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • GSA Capital Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 5,819 Exact Sciences shares in Q1 2026, an estimated $591K.
  • GSA Capital Partners first reported a position in Exact Sciences in Q3 2014 and held it in 15 quarters.
  • GSA Capital Partners's Exact Sciences position peaked at $1.46M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.